Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $11.2400 (-0.88%) ($11.2400 - $11.2400) on Fri. Apr. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.02% (three month average) | RSI | 60 | Latest Price | $11.2400(-0.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 2% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(40%) IWO(36%) ARKG(34%) ARKK(34%) | Factors Impacting BCRX price | BCRX will decline at least -3.51% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-7%) TBT(-2%) IGOV(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.51% (StdDev 7.02%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $10.39(8.18%) | 10 Day Moving Average | $10.33(8.81%) | 20 Day Moving Average | $10.5(7.05%) | To recent high | -17.5% | To recent low | 30.7% | Market Cap | $1.983b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |